PGP and neoplasm: These observations indicated that the residual of the drug-resistant tumour cells could be eradicated by the addition of low concentrations of anti-Cripto Mab to the originally unresponsive concentrations of chemotherapeutic Pgp substrates to prevent tumour cells from recurrence.